Clinical Trials for Remix Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Remix Therapeutics

Clinical Trials (2)

NCT06297941
Study of REM-422 in Patients With AML or Higher Risk MDS
PHASE1Recruiting
100 participants
Started: Apr 26, 2024 · Completed: Jun 15, 2027
4 conditions1 sponsor9 locations
NCT06118086
Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
PHASE1Recruiting
65 participants
Started: Dec 20, 2023 · Completed: Jun 1, 2027
3 conditions1 sponsor8 locations